All About MS » lesions

Rituximab News

Posted on March 19th, 2009

In the development of new therapies for multiple sclerosis, there are occasions in which the results of a study surprise investigators and challenge their long-held beliefs about MS. A recent example is the evolving story concerning the development of a drug called rituximab as a treatment for MS, specifically read more »

Categories: MS Tags: drug, lesions, MRI, MS, multiple sclerosis, placebo, primary progressive, Primary Progressive MS, Research, Ritusan, Rituximab, therapy, treatment

Study to compare Avonex plus a placebo to Ocrelizumab

Posted on February 27th, 2009

A randomized, placebo and active-controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 dose regimens of ocrelizumab in patients read more »

Categories: Rituximab Tags: Avonex, drug trial, lesions, MRI, MS, multiple sclerosis, ocrelizumab, Phase II Study, placebo, relapsin remitting multiple sclerosis, trial

Search for:
The AllAboutMS blog is dedicated to providing news and information about Multiple Sclerosis, maintained by the research done by Bonnie. Bonnie was diagnosed with MS in 1995.

If you want this blog to continue, then make it financially viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Categories
Recent Comments
- Bonnie on Vitamin D May Lessen Age-related Cognitive Decline
- Carmelle Mills on Vitamin D May Lessen Age-related Cognitive Decline

Posts related to lesions

Rituximab News

Study to compare Avonex plus a placebo to Ocrelizumab